Literature DB >> 8930903

Bound simian virus 40 translocates to caveolin-enriched membrane domains, and its entry is inhibited by drugs that selectively disrupt caveolae.

H A Anderson1, Y Chen, L C Norkin.   

Abstract

Simian virus 40 (SV40) entry leading to infection occurred only after the virus was at the cell surface for 1.5 to 2 h. SV40 infectious entry was not sensitive to cytosol acidification, a treatment that blocks endocytosis via clathrin-coated vesicles. Instead, SV40 infectious entry was blocked by treating cells with the phorbol ester PMA or nystatin, which selectively disrupts caveolae. In control experiments, transferrin internalization was sensitive to cytosol acidification but was not sensitive to PMA or nystatin. Also, absorbed transferrin entered cells within minutes. Finally, bound SV40 translocated to caveolin-enriched membrane complexes isolated by a Triton X-100 insolubility protocol. Treatment with nystatin did not impair SV40 binding but did block the partitioning of virus into the caveolin-enriched complexes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8930903      PMCID: PMC276029          DOI: 10.1091/mbc.7.11.1825

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  48 in total

1.  Early events in polyoma virus infection: attachment, penetration, and nuclear entry.

Authors:  R L Mackay; R A Consigli
Journal:  J Virol       Date:  1976-08       Impact factor: 5.103

Review 2.  Multiple stages of virus-receptor interactions as shown by simian virus 40.

Authors:  L C Norkin; H A Anderson
Journal:  Adv Exp Med Biol       Date:  1996       Impact factor: 2.622

Review 3.  Signal-dependent membrane protein trafficking in the endocytic pathway.

Authors:  I S Trowbridge; J F Collawn; C R Hopkins
Journal:  Annu Rev Cell Biol       Date:  1993

4.  Non-coated membrane invaginations are involved in binding and internalization of cholera and tetanus toxins.

Authors:  R Montesano; J Roth; A Robert; L Orci
Journal:  Nature       Date:  1982-04-15       Impact factor: 49.962

5.  Infectious entry pathway of adenovirus type 2.

Authors:  M J Varga; C Weibull; E Everitt
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

6.  Endothelial caveolae have the molecular transport machinery for vesicle budding, docking, and fusion including VAMP, NSF, SNAP, annexins, and GTPases.

Authors:  J E Schnitzer; J Liu; P Oh
Journal:  J Biol Chem       Date:  1995-06-16       Impact factor: 5.157

7.  Ultrastructural evidence of differential solubility in Triton X-100 of endothelial vesicles and plasma membrane.

Authors:  N I Moldovan; C Heltianu; N Simionescu; M Simionescu
Journal:  Exp Cell Res       Date:  1995-07       Impact factor: 3.905

Review 8.  Caveolae: static inpocketings of the plasma membrane, dynamic vesicles or plain artifact?

Authors:  N J Severs
Journal:  J Cell Sci       Date:  1988-07       Impact factor: 5.285

9.  Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease.

Authors:  M P Lisanti; P E Scherer; J Vidugiriene; Z Tang; A Hermanowski-Vosatka; Y H Tu; R F Cook; M Sargiacomo
Journal:  J Cell Biol       Date:  1994-07       Impact factor: 10.539

10.  Caveolin forms a hetero-oligomeric protein complex that interacts with an apical GPI-linked protein: implications for the biogenesis of caveolae.

Authors:  M P Lisanti; Z L Tang; M Sargiacomo
Journal:  J Cell Biol       Date:  1993-11       Impact factor: 10.539

View more
  163 in total

Review 1.  Caveolae: an alternative membrane transport compartment.

Authors:  M Gumbleton; A G Abulrob; L Campbell
Journal:  Pharm Res       Date:  2000-09       Impact factor: 4.200

2.  Neuronal activity-dependent membrane traffic at the neuromuscular junction.

Authors:  Francisco Javier Miana-Mena; Sylvie Roux; Jean-Claude Benichou; Rosario Osta; Philippe Brûlet
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-05       Impact factor: 11.205

3.  Caveolae are involved in the trafficking of mouse polyomavirus virions and artificial VP1 pseudocapsids toward cell nuclei.

Authors:  Z Richterová; D Liebl; M Horák; Z Palková; J Stokrová; P Hozák; J Korb; J Forstová
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

4.  Specific association of glycoprotein B with lipid rafts during herpes simplex virus entry.

Authors:  Florent C Bender; J Charles Whitbeck; Manuel Ponce de Leon; Huan Lou; Roselyn J Eisenberg; Gary H Cohen
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

5.  Assembly of endocytic machinery around individual influenza viruses during viral entry.

Authors:  Michael J Rust; Melike Lakadamyali; Feng Zhang; Xiaowei Zhuang
Journal:  Nat Struct Mol Biol       Date:  2004-05-02       Impact factor: 15.369

6.  Cholera toxin toxicity does not require functional Arf6- and dynamin-dependent endocytic pathways.

Authors:  Ramiro H Massol; Jakob E Larsen; Yukako Fujinaga; Wayne I Lencer; Tomas Kirchhausen
Journal:  Mol Biol Cell       Date:  2004-05-14       Impact factor: 4.138

Review 7.  Hijacking the endocytic machinery by microbial pathogens.

Authors:  Ann En-Ju Lin; Julian Andrew Guttman
Journal:  Protoplasma       Date:  2010-06-25       Impact factor: 3.356

8.  Immunolocalization of caveolin-1 in rat and human mesothelium.

Authors:  Christopher J von Ruhland; Lee Campbell; Mark Gumbleton; Bharat Jasani; Geoffrey R Newman
Journal:  J Histochem Cytochem       Date:  2004-11       Impact factor: 2.479

9.  High-throughput cell-based screen for chemicals that inhibit infection by simian virus 40 and human polyomaviruses.

Authors:  Edward C Goodwin; Walter J Atwood; Daniel DiMaio
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

10.  Itinerary of hepatitis B viruses: delineation of restriction points critical for infectious entry.

Authors:  Anneke Funk; Mouna Mhamdi; Li Lin; Hans Will; Hüseyin Sirma
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.